Vor Biopharma
Kevin Pimental, CPA, currently serves as the Director of Technical Accounting & SEC Reporting at Vor Bio since September 2025. Prior to this role, Kevin held the position of Associate Director of SEC Reporting and Technical Accounting at iTeos Therapeutics from June 2022 to September 2025, and served as Senior Manager of SOX Compliance and Technical Accounting at Finch Therapeutics from January 2022 to June 2022. Kevin's earlier experience includes working as a Technical Accounting Manager at Ortho Clinical Diagnostics from August 2020 to December 2021 and progressing through various roles at PwC from January 2014 to August 2020, culminating as Assurance Manager. Kevin earned a Bachelor's of Science in Business Administration with a specialization in Accounting and a minor in Economics from The Ohio State University between 2009 and 2013.
This person is not in the org chart
This person is not in any teams
This person is not in any offices